ERBB2 and breast carcinoma: Of importance, exosomes derived from leptin-treated breast cancer cells display an higher levels of Hsp90, along with other leptin-related molecules such as HER2, pSTAT3, pJAK2 and pMAPK compared to exosomes released from vehicle-treated cells.